Reply: Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'
暂无分享,去创建一个
R. Bloigu | J. Väyrynen | K. Herzig | M. Mäkinen | T. Karttunen | J. Mäkelä | T. Karhu | T. Kantola | K. Klintrup | A. Tuomisto | J. Vornanen | J. Näpänkangas
[1] D. McMillan,et al. Comment on ‘Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma' , 2013, British Journal of Cancer.
[2] R. Palmqvist,et al. The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer , 2012, PloS one.
[3] R. Bloigu,et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma , 2012, British Journal of Cancer.
[4] Zhi-ren Zhang,et al. Macrophages in Tumor Microenvironments and the Progression of Tumors , 2012, Clinical & developmental immunology.
[5] P. Pauwels,et al. Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy , 2011, Clinical & developmental immunology.
[6] T. Fry,et al. Harnessing the biology of IL-7 for therapeutic application , 2011, Nature Reviews Immunology.
[7] Giacomo Puppa,et al. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. , 2010, Archives of pathology & laboratory medicine.
[8] D. McMillan,et al. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. , 2010, Future oncology.
[9] V. Colantuoni,et al. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. , 2009, Human pathology.
[10] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[11] J. Melkko,et al. Inflammation and prognosis in colorectal cancer. , 2005, European journal of cancer.
[12] C. Ko,et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.
[13] V. Kosma,et al. Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.
[14] C. Casciani,et al. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression , 1996, Cancer Immunology, Immunotherapy.
[15] P. Leder,et al. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.